These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16644063)

  • 1. Thymosin alpha1 suppresses proliferation and induces apoptosis in human leukemia cell lines.
    Fan YZ; Chang H; Yu Y; Liu J; Wang R
    Peptides; 2006 Sep; 27(9):2165-73. PubMed ID: 16644063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A modified thymosin alpha 1 inhibits the growth of breast cancer both in vitro and in vivo: suppressment of cell proliferation, inducible cell apoptosis and enhancement of targeted anticancer effects.
    Lao X; Li B; Liu M; Shen C; Yu T; Gao X; Zheng H
    Apoptosis; 2015 Oct; 20(10):1307-20. PubMed ID: 26283169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The anti-tumor efforts of thymosin alpha1 on tumor lysate-pulsed dendritic cells in colon cancer in vitro and in vivo].
    Ma YL; Zheng Z; Li BD; Xie SJ; Li GX; Yan QH; Cai JH
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Nov; 23(11):1046-9. PubMed ID: 17988589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulatory and enhanced antitumor activity of a modified thymosin α1 in melanoma and lung cancer.
    Wang F; Li B; Fu P; Li Q; Zheng H; Lao X
    Int J Pharm; 2018 Aug; 547(1-2):611-620. PubMed ID: 29933059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression, purification and characterization of a novel soluble human thymosin alpha1 concatemer exhibited a stronger stimulation on mice lymphocytes proliferation and higher anti-tumor activity.
    Li W; Song L; Wu S; Xue X; Zhang L; He L; Han W; Wang Q; Ling R; Zhang W; Yan Z; Zhang Y
    Int J Biol Sci; 2011; 7(5):618-28. PubMed ID: 21647330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferative and anti-proliferative effects of thymosin alpha1 on cells are associated with manipulation of cellular ROS levels.
    Qin Y; Chen FD; Zhou L; Gong XG; Han QF
    Chem Biol Interact; 2009 Aug; 180(3):383-8. PubMed ID: 19442654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The in vivo immunomodulatory and synergistic anti-tumor activity of thymosin α1-thymopentin fusion peptide and its binding to TLR2.
    Li J; Cheng Y; Zhang X; Zheng L; Han Z; Li P; Xiao Y; Zhang Q; Wang F
    Cancer Lett; 2013 Sep; 337(2):237-47. PubMed ID: 23684552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitization and apoptosis augmentation of K562/ADM cells by anti-multidrug resistance gene peptide nucleic acid and antisense oligodeoxyribonucleotide.
    Wei HL; Wu YJ; Jing T; Bai DC; Ma LF
    Acta Pharmacol Sin; 2003 Aug; 24(8):805-11. PubMed ID: 12904281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymosin alpha1. SciClone Pharmaceuticals.
    Billich A
    Curr Opin Investig Drugs; 2002 May; 3(5):698-707. PubMed ID: 12090542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymosin α1 promotes the activation of myeloid-derived suppressor cells in a Lewis lung cancer model by upregulating Arginase 1.
    Yuan C; Zheng Y; Zhang B; Shao L; Liu Y; Tian T; Gu X; Li X; Fan K
    Biochem Biophys Res Commun; 2015 Aug; 464(1):249-55. PubMed ID: 26111447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a C-end rule modification on antitumor activity of thymosin α1.
    Wang F; Xu C; Peng R; Li B; Shen X; Zheng H; Lao X
    Biochimie; 2018 Nov; 154():99-106. PubMed ID: 30096371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymosin alpha1 is a time and dose-dependent antagonist of dexamethasone-induced apoptosis of murine thymocytes in vitro.
    Baumann CA; Badamchian M; Goldstein AL
    Int J Immunopharmacol; 2000 Dec; 22(12):1057-66. PubMed ID: 11137612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal growth inhibition as a bioassay for thymosin alpha1: inactivation of Talpha1 by trifluroacetic acid.
    Bianco-Batlles D; Naylor CW; Moshier JA; Dosescu J; Naylor PH
    Cell Mol Biol (Noisy-le-grand); 2001 Feb; 47(1):157-60. PubMed ID: 11292250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression and Activity Regulation of Indoleamine 2,3-Dioxygenase in Acute Myeloid Leukemia Cells].
    Liao J; Li YP; Huang JM; Li G
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Dec; 24(6):1633-1638. PubMed ID: 28024468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. beta(2)-microglobulin induces apoptosis in HL-60 human leukemia cell line and its multidrug resistant variants overexpressing MRP1 but lacking Bax or overexpressing P-glycoprotein.
    Wu CH; Rastegar M; Gordon J; Safa AR
    Oncogene; 2001 Oct; 20(48):7006-20. PubMed ID: 11704825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A tumor-penetrating peptide modification enhances the antitumor activity of thymosin alpha 1.
    Lao X; Liu M; Chen J; Zheng H
    PLoS One; 2013; 8(8):e72242. PubMed ID: 23977262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of apoptosis in K562/ADM cells by gamma-linolenic acid involves lipid peroxidation and activation of caspase-3.
    Kong X; Ge H; Hou L; Shi L; Liu Z
    Chem Biol Interact; 2006 Aug; 162(2):140-8. PubMed ID: 16857180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the immunomodulating peptide thymosin alpha 1 on multiple myeloma and immune recovery after hematopoietic stem cell transplantation.
    Binsfeld M; Hannon M; Otjacques E; Humblet-Baron S; Baudoux E; Beguin Y; Baron F; Caers J
    Cancer Immunol Immunother; 2015 Aug; 64(8):989-98. PubMed ID: 25971542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arsenic trioxide induces apoptosis in leukemia/lymphoma cell lines via the CD95/CD95L system.
    Zhu J; Okumura H; Ohtake S; Nakamura S; Nakao S
    Oncol Rep; 2003; 10(3):705-9. PubMed ID: 12684647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. By activating Fas/ceramide synthase 6/p38 kinase in lipid rafts, stichoposide D inhibits growth of leukemia xenografts.
    Yun SH; Park ES; Shin SW; Ju MH; Han JY; Jeong JS; Kim SH; Stonik VA; Kwak JY; Park JI
    Oncotarget; 2015 Sep; 6(29):27596-612. PubMed ID: 26318294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.